Zika virus effectin couple months, it can gain 100% easily查看全文
Nicole07772016-02-10 23:26
$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx BioPharma Shares Gain; Mulls Zika Virus Research Program (NYSEMKT:HEB)
网页链接查看全文
Nicole07772015-06-25 22:31
$HEMISPHERX BIOPHARMA INC(HEB)$ Hemispherx Biopharma (HEB) Announces EPO to Grant Rugged dsRNA-Related Patent
网页链接(HEB)+Announces+EPO+to+Grant+Rugged+dsRNA-Related+Patent/10678616.html查看全文
Nicole07772015-07-08 00:26
$HEMISPHERX BIOPHARMA INC(HEB)$ $HEB: Institutional investors increased their holdings in HEB by 8.98% Q/Q, with 1,422,540 net purchase. 23 institutions have a holding in HEB shares. These institutional investors hold 6% of HEB's total shares and 6% of its float. Insiders...查看全文
Nicole07772015-07-08 02:19
$HEMISPHERX BIOPHARMA INC(HEB)$ UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A(Rule 14a-101)
网页链接查看全文
Nicole07772016-02-04 00:17
$HEMISPHERX BIOPHARMA INC(HEB)$ Zika virus outbreaks in Texas (US) and in Düsseldorf (Germany) 查看全文
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-26 AccNo: 0001493152-19-013386 Size: 83 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Oth...
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-08-23 AccNo: 0001493152-19-013294 Size: 62 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-20 AccNo: 0001493152-19-013142 Size: 1 MB 网页链接
$Hemispherx Biopharma(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001493152-19-012572 Size: 5 MB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-07-22 AccNo: 0001493152-19-010919 Size: 319 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx Biopharma(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-07-22 AccNo: 0001493152-19-010927 Size: 480 KB 网页链接
$Hemispherx Biopharma(HEB)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-06-28 AccNo: 0001493152-19-009885 Size: 54 KB 网页链接
$Hemispherx Biopharma(HEB)$ 8-K - Current report Filed: 2019-06-28 AccNo: 0001493152-19-009853 Size: 73 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fin...
$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-27,Exec. 副Chairman/CEO/Pres.,EQUELS THOMAS K. ,买入,2632普通股, $4.37
$Hemispherx Biopharma(HEB)$ 内部交易: 2019-06-21,Director,MITCHELL WILLIAM M ,买入,9677普通股, $4.03